Topic: How To Invest

Power Growth Investor Hotline – Friday, April 4, 2025

Article Excerpt

RESMED INC., $205.17, is a buy. The firm, symbol RMD on New York, helps investors tap the growing market for medical devices used to treat sleep apnea. ResMed’s CPAP (nasal continuous positive airway pressure) devices are also used to treat patients with chronic obstructive pulmonary disease as well as other respiratory conditions. With each new machine ResMed sells, it also acquires a potential long-term customer for replacement parts. They include tubing, masks and so on, which must be replaced several times a year and so provide steady recurring revenue. Still, a key first step for the company remains the need to identify future customers. ResMed’s home sleep apnea test, NightOwl, is now available across the U.S. and it should help the company with that first step. NightOwl is an FDA-cleared home sleep apnea test designed to offer healthcare providers a simplified, accurate, and efficient way to diagnose obstructive sleep apnea from the comfort of an individual’s home. Obstructive sleep apnea, a sleep disorder where…